Clinical Trial Update: Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of colesevelam hydrochloride (WelChol) on insulin sensitivity in adults with type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED